Precision management of cervical cancer emphasizes immunotherapy combination regimens and translational advances

Abstract Cervical cancer remains a major global health burden, particularly in settings with limited access to screening and human papillomavirus (HPV) vaccination. Although surgery and chemoradiation can achieve high cure rates in early-stage disease, outcomes for persistent, recurrent, or metastat...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Huan Shi, Xinyun Huang, Jie Yu, Weiyan Shan, Jingxia Zhang, Qiaoping Xu, Hongkai Shang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer 2026-02-01
Edice:	Discover Oncology
Témata:	Cervical cancer Immune checkpoint inhibition Immunotherapy PD-1 CTLA-4
On-line přístup:	https://doi.org/10.1007/s12672-026-04588-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!